checkAd

    TRANSMETA: Zahlen?! - 500 Beiträge pro Seite

    eröffnet am 15.01.04 22:22:40 von
    neuester Beitrag 15.01.04 22:31:19 von
    Beiträge: 4
    ID: 810.914
    Aufrufe heute: 0
    Gesamt: 419
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 15.01.04 22:22:40
      Beitrag Nr. 1 ()
      Sollten heute nicht die Zahlen kommen?
      Hab Besuch :rolleyes: & kann nicht nach Infos suchen.

      Wäre sehr verbunden ... ;o)
      Avatar
      schrieb am 15.01.04 22:26:19
      Beitrag Nr. 2 ()
      SANTA CLARA, Calif.--

      Balance Sheet Strengthened by $78.4 Million from Common Stock
      Offering First Efficeon-Based Product Is Shipping


      Transmeta Corporation (Nasdaq:TMTA), the leader in efficient
      computing, today announced financial results for its fourth quarter
      and fiscal year ended December 26, 2003.

      Net revenue for the fourth quarter of fiscal 2003 was $3.6
      million, compared with $2.7 million in the third quarter of 2003 and
      $6.1 million in the fourth quarter of 2002. GAAP net loss for the
      fourth quarter of 2003 was $21.6 million, or a loss of $0.15 per
      share. This compares with a GAAP net loss of $23.7 million, or a loss
      of $0.17 per share in the third quarter of 2003 and a GAAP net loss of
      $21.7 million, or a loss of $0.16 per share in the fourth quarter of
      2002.

      Excluding the net effects of non-cash charges and credits of $3.2
      million, the non-GAAP net loss for the fourth quarter of 2003 was
      $18.4 million, or a net loss of $0.13 per share. This compares with a
      non-GAAP net loss of $18.7 million, which excludes net non-cash
      charges of $4.9 million, or a net loss of $0.13 per share in the third
      quarter of 2003, and a non-GAAP net loss of $17.6 million, which
      excludes net non-cash charges of $4.1 million, or a net loss of $0.13
      per share in the fourth quarter of 2002.

      In December 2003, Transmeta received net proceeds, before
      expenses, of $68.2 million from its common stock offering of 25
      million shares, bringing its total cash and equivalents to $120.8
      million at year end. On January 12, 2004 the underwriters exercised
      their over-allotment option and purchased 3.75 million shares,
      resulting in additional net proceeds to the company of $10.2 million,
      and bringing the total net proceeds to $78.4 million before expenses
      and giving the company a post-offering cash and equivalents balance of
      approximately $130.0 million.

      Net revenue for fiscal 2003 was $17.3 million, compared with $24.2
      million for fiscal 2002. GAAP net loss for fiscal 2003 was $87.3
      million, or a loss of $0.62 per share. This compares with a GAAP net
      loss of $110.0 million, or a loss of $0.82 per share in 2002.

      Non-GAAP net loss for fiscal 2003 was $72.4 million, or a loss of
      $0.52 per share, which excludes net non-cash charges and credits
      totaling $14.9 million. This compares with a non-GAAP net loss of
      $83.9 million, or a loss of $0.62 per share in fiscal 2002, which
      excludes restructuring and non-cash charges as well as the benefit
      from previously recorded inventory-related charges totaling $26.0
      million.

      "In the fourth quarter, we achieved revenue within our guidance
      range and strengthened our balance sheet by more than $78 million in
      net proceeds from our common stock offering, including the
      over-allotment option the underwriters exercised in January," said Dr.
      Matthew R. Perry, president and CEO of Transmeta.

      "Mobile computing design activity is shifting to our Efficeon(TM)
      processor and we are beginning to see the revenue associated with this
      new product. Our embedded designs -- particularly in the thin client
      space -- are also beginning to contribute significant revenue. We
      believe that the majority of our growth in 2004 will be derived from
      the mobile computing and thin client markets. In addition, we continue
      to receive strong interest in licensing opportunities for our
      power-management technologies.

      "We are excited that our first Efficeon-powered notebook, Sharp`s
      MM2, began selling in Japan recently. In addition, we have many
      Efficeon designs currently in development, most of which are planned
      for shipment beginning in the second quarter of 2004. There is also
      significant interest in our next-generation 90-nanometer Efficeon
      processor. Our goal is to produce the 90 nanometer generation of
      Efficeon processors in the second half of 2004," said Dr. Perry.


      Highlights


      -- Sharp recently began shipping its Mebius Muramasa PC MM2, the
      first Efficeon-powered notebook to be announced in the market.
      The new version of the Muramasa, which is available in Japan
      and uses Transmeta`s Efficeon TM8600 processor, weighs only
      910 grams and is about a half an inch thin.


      -- OQO announced its Ultra-Personal Computer (UPC) Model 01 at
      CES last week where it was a Tech TV`s Best of CES 2004 winner
      for the mobile computing/wireless segment. The Model 01 weighs
      only 14 ounces and is 4.9 inches by 3.4 inches by 0.9 inches,
      is powered by a Transmeta Crusoe(R) TM5800 processor and is
      expected to be available in the fall of 2004.


      -- Hewlett-Packard announced that it has chosen Transmeta`s
      Efficeon processor to power the Blade PC in its new
      Consolidated Client Infrastructure (CCI). HP`s CCI, designed
      to dramatically lower total cost of ownership without
      compromising desktop performance or end-user experience,
      consists of an access device - an HP thin client powered by
      Transmeta`s Crusoe processor - that connects with the HP Blade
      PC, powered by Transmeta`s new Efficeon processor. HP thin
      clients are currently available and the HP Blade PC is
      expected to be available in the US and in Canada in the first
      quarter of 2004.


      -- Wyse Technology announced that it is collaborating with
      Transmeta to develop non-PC desktops based on Transmeta`s
      processors. Wyse will work with Transmeta to research and
      develop innovative PC alternative platforms that address the
      evolving information access needs of the enterprise IT market.


      -- Transmeta introduced its Crusoe TM5700 and TM5900 processors,
      which make the company`s proven Crusoe processors available in
      a new 21mm by 21mm package, representing an approximate 50
      percent reduction in package size over the company`s Crusoe
      TM5800 processor. The small footprint of the Transmeta Crusoe
      TM5700 and TM5900 processors make them ideal for applications
      that require high performance processing within small and
      thermally constrained environments.


      -- Additional highlights include: Antelope Technologies began
      shipping the world`s first UPC, Dialogue Technology began
      sampling its FlyBook Ultraportable Notebook PC, Microtel began
      shipping its 1007 Wireless Notebook, NEC upgraded its NetBrain
      CS58 server series, Xybernaut announced general availability
      of its Atigo T flat panel computer and Zupera Technology
      introduced its Smartbook 8XP mini-notebook. All these new
      products are powered by Transmeta`s Crusoe processors.


      Current Financial Outlook for First Quarter 2004


      The following outlook statements are based upon current
      expectations. These statements are forward looking, and actual results
      could differ materially.

      The company currently expects first quarter revenue to be between
      $5.0 million and $6.0 million. GAAP net loss per share for the first
      quarter is expected to be in the range of $0.13 to $0.14 and a
      non-GAAP net loss per share in the range of $0.11 to $0.12 on about
      171.6 million weighted average shares outstanding. The expected
      non-GAAP net loss per share excludes the effect of non-cash
      amortization and deferred compensation charges, which are expected to
      total $2.6 million for the first quarter. Operating expenses are
      expected to be approximately $19.2 million. Cash and equivalents at
      the end of March is expected to be approximately $113.0 million.


      Conference Call


      The company will hold a conference call at 2:00 pm Pacific Time
      today, January 15, 2004, to discuss the fourth quarter and fiscal 2003
      financial results. To participate, please dial (719) 457-2617 at
      approximately 1:50 pm PT. A live webcast of the conference call will
      be available via the investor relations page of the company`s website
      at www.transmeta.com. A replay of the call will be available one hour
      after the completion of the call. To access the recording, please dial
      (888) 203-1112, passcode 790532. For callers outside the U.S., please
      dial (719) 457-0820, with the same passcode.


      About Transmeta Corporation


      Founded in 1995, Transmeta Corporation designs, develops and sells
      highly efficient x86-compatible software-based microprocessors that
      deliver a compelling balance of low power consumption, high
      performance, low cost and small size. We announced our first Crusoe
      family of processors in 2000, and we introduced our new Efficeon
      family of processors in October 2003. Our products are valuable for
      diverse computing platforms demanding energy efficiency, low heat and
      x86 software compatibility. We also develop advanced power management
      technologies for controlling leakage and increasing power efficiency
      in semiconductor and computing devices. To learn more about Transmeta,
      visit www.transmeta.com.


      Safe Harbor Statement


      This release contains forward-looking statements made pursuant to
      the safe harbor provisions of the Private Securities Litigation Reform
      Act of 1995. Such statements speak only as of the date of this
      release, and we will not necessarily provide updates of our
      projections or other forward-looking statements. Investors are
      cautioned that such forward-looking statements are subject to many
      risks and uncertainties, and may differ materially or adversely from
      our actual results or future events. Important risk factors that could
      have material or adverse effects on our results include general
      economic, political and public health conditions, specific conditions
      and volatility in the markets that we address, the rescheduling or
      cancellation of significant customer orders, market acceptance and
      adoption of our new products by our present and future customers and
      end users, difficulties in developing or manufacturing new and
      existing products in a timely and cost effective manner, our
      dependence on third parties for sourcing materials and providing
      manufacturing services, intense competition and competitive pressures,
      patents and other intellectual property rights, and other risk
      factors. We urge investors to review our filings with the Securities
      and Exchange Commission, including our recent reports on Forms 8-K,
      10-K and 10-Q, which describe these and other important risk factors
      that could have an adverse effect on our results. We undertake no
      obligation to revise or update publicly any forward-looking statement
      for any reason.

      -0-
      *T
      TRANSMETA CORPORATION
      CONDENSED CONSOLIDATED
      STATEMENTS OF OPERATIONS

      (in thousands, except per share amounts)


      Three Months Ended Fiscal Year Ended
      ------------------- -------------------
      Dec 26, Dec 27, Dec 26, Dec 27,
      2003 2002 2003 2002
      --------- --------- --------- ----------

      Net revenue $ 3,556 $ 6,118 $ 17,315 $ 24,247
      Cost of revenue 3,801 4,680 16,324 17,127
      --------- --------- --------- ----------
      Gross profit (245) 1,438 991 7,120

      Operating expenses
      Research and development 11,404 12,632 48,525 63,603
      Selling, general and
      administrative 6,795 6,991 25,754 29,917
      Restructuring charges (147) - (147) 14,726
      Amortization of deferred
      charges and intangible assets 2,628 2,848 10,530 11,392
      Stock compensation 696 1,214 4,529 1,809
      --------- --------- --------- ----------
      Total operating expenses 21,376 23,685 89,191 121,447
      --------- --------- --------- ----------
      Operating loss (21,621) (22,247) (88,200) (114,327)
      Interest and other, net 53 561 912 4,361
      --------- --------- --------- ----------
      Net loss $(21,568) $(21,686) $(87,288) $(109,966)
      ========= ========= ========= ==========

      Net loss per share--basic and
      diluted $ (0.15) $ (0.16) $ (0.62) $ (0.82)

      Weighted average shares
      outstanding - basic and
      diluted 142,747 136,850 139,692 134,719


      TRANSMETA CORPORATION
      PRO FORMA CONDENSED CONSOLIDATED
      STATEMENTS OF OPERATIONS

      (in thousands, except per share amounts)

      The following pro forma supplemental information excludes the
      amortization of deferred charges and intangible assets, non-cash stock
      compensation awards, restructuring charges, and effects of previously
      recorded inventory commitments


      Three Months Ended Fiscal Year Ended
      ------------------- --------------------
      Dec 26, Dec 27, Dec 26, Dec 27,
      2003 2002 2003 2002
      --------- --------- --------- ----------


      Net revenue $ 3,556 $ 6,118 $ 17,315 $ 24,247
      Cost of revenue 3,801 4,680 16,324 19,012
      --------- --------- --------- ----------
      Gross profit (245) 1,438 991 5,235

      Operating expenses
      Research and development 11,404 12,632 48,525 63,603
      Selling, general and
      administrative 6,795 6,991 25,754 29,917
      --------- --------- --------- ----------
      Total operating expenses 18,199 19,623 74,279 93,520
      --------- --------- --------- ----------
      Operating loss (18,444) (18,185) (73,288) (88,285)
      Interest and other, net 53 561 912 4,361
      --------- --------- --------- ----------
      Net loss $(18,391) $(17,624) $(72,376) $ (83,924)
      ========= ========= ========= ==========

      Net loss per share--basic and
      diluted $ (0.13) $ (0.13) $ (0.52) $ (0.62)

      Weighted average shares
      outstanding - basic and
      diluted 142,747 136,850 139,692 134,719

      The pro forma amounts have been adjusted to eliminate the following:

      Amortization of deferred charges
      and intangible assets $ 2,628 $ 2,848 $ 10,530 $ 11,392
      Stock compensation 696 1,214 4,529 1,809
      Restructuring charges (147) - (147) 14,726
      Excess inventory and purchase
      commitment charge - - - (1,885)

      Net loss in accordance with
      U.S. GAAP $(21,568) $(21,686) $(87,288) $(109,966)



      TRANSMETA CORPORATION
      CONDENSED CONSOLIDATED BALANCE SHEETS

      (in thousands)

      Dec. 26, Dec. 27,
      2003 2002
      --------- ---------
      Assets
      Current assets
      Cash and short-term investments $120,765 $129,450
      Accounts receivable, net 1,914 4,060
      Inventories 8,796 10,937
      Prepaid and other current assets 3,671 4,722
      --------- ---------
      Total current assets 135,146 149,169
      Property and equipment, net 5,305 9,574
      Other assets 31,334 38,812
      --------- ---------
      Total assets $171,785 $197,555
      ========= =========

      Liabilities and Stockholders` Equity
      Current liabilities
      Accounts payable and other current liabilities $ 11,996 $ 13,722
      Current portion of accrued restructuring costs 1,667 2,549
      Current portion of long-term obligations 21,499 16,865
      --------- ---------
      Total current liabilities 35,162 33,136
      Long-term accrued restructuring costs 4,501 5,456
      Long-term payables 356 18,116
      Stockholders` equity 131,766 140,847
      --------- ---------
      Total liabilities and stockholders` equity $171,785 $197,555
      ========= =========
      *T
      Transmeta Corporation S. Olav Carlsen, 408-919-3000 or Mozes
      Communications LLC Kristine Mozes, 781-652-8875
      © Business Wire, 2004 - 01/15/2004 04:07 PM
      Avatar
      schrieb am 15.01.04 22:30:59
      Beitrag Nr. 3 ()
      DANKE! :kiss:
      Avatar
      schrieb am 15.01.04 22:31:19
      Beitrag Nr. 4 ()


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      TRANSMETA: Zahlen?!